Sales decline 8.45% to Rs 58.91 crore
Net Loss of Bal Pharma reported to Rs 0.34 crore in the quarter ended March 2018 as against net loss of Rs 1.83 crore during the previous quarter ended March 2017. Sales declined 8.45% to Rs 58.91 crore in the quarter ended March 2018 as against Rs 64.35 crore during the previous quarter ended March 2017.For the full year,net profit reported to Rs 0.38 crore in the year ended March 2018 as against net loss of Rs 0.74 crore during the previous year ended March 2017. Sales declined 9.88% to Rs 211.75 crore in the year ended March 2018 as against Rs 234.96 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales58.9164.35 -8 211.75234.96 -10 OPM %9.764.76 -8.206.12 - PBDT2.841.67 70 9.658.85 9 PBT0.87-0.58 LP 2.882.36 22 NP-0.34-1.83 81 0.38-0.74 LP
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
